These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 1689470)

  • 1. Effects of chronic treatment with haloperidol and bromocriptine on the processing of beta-endorphin to gamma- and alpha-endorphin in discrete regions of the rat pituitary gland and brain.
    Sweep CG; Boersma CJ; Wiegant VM
    Neuropharmacology; 1990 Jan; 29(1):61-8. PubMed ID: 1689470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term haloperidol treatment elevates beta-endorphin levels in the intermediate pituitary but not in rat brain.
    Millington WR; Maiewski S; O'Donohue TL; Mueller GP
    Neuropeptides; 1985 Jul; 6(4):365-72. PubMed ID: 2931616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leu-Phe cleaving endopeptidase activity, gamma-endorphin, and beta-endorphin in the rat pituitary gland and brain. Effect of adrenalectomy and corticosterone substitution.
    Lebouille JL; Burbach JP; De Kloet ER; Wiegant VM; Sweep CG; De Wied D
    Neuroendocrinology; 1988 Jan; 47(1):7-12. PubMed ID: 2448702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of acute and chronic haloperidol treatment on the concentrations of immunoreactive beta-endorphin in plasma, pituitary and brain of rats.
    Höllt V; Bergmann M
    Neuropharmacology; 1982 Feb; 21(2):147-54. PubMed ID: 6278359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ceruletide and haloperidol on the hypothalamo-pituitary beta-endorphin system and brain beta-endorphin contents in the rat: with special reference to effects of ceruletide in chronically haloperidol-treated rats.
    Hagino Y; Okuwa M; Moroji T
    Neuropeptides; 1991 Jan; 18(1):1-14. PubMed ID: 2046884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coordinate regulation of peptide acetyltransferase activity and proopiomelanocortin gene expression in the intermediate lobe of the rat pituitary.
    Millington WR; O'Donohue TL; Chappell MC; Roberts JL; Mueller GP
    Endocrinology; 1986 May; 118(5):2024-33. PubMed ID: 2938933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic agents selectively alter the post-translational processing of beta-endorphin in the intermediate pituitary of the rat.
    Millington WR; O'Donohue TL; Mueller GP
    J Pharmacol Exp Ther; 1987 Oct; 243(1):160-70. PubMed ID: 2959768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic agents differentially alter beta-endorphin processing patterns in the rat pituitary neurointermediate lobe.
    Autelitano DJ; Smith AI; Lolait SJ; Funder JW
    Neurosci Lett; 1985 Aug; 59(1):141-6. PubMed ID: 2931629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of tuberohypophysial dopaminergic neurons terminating in the intermediate lobe and in the neural lobe of the rat pituitary gland.
    Lookingland KJ; Farah JM; Lovell KL; Moore KE
    Neuroendocrinology; 1985 Feb; 40(2):145-51. PubMed ID: 3156283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of acute and chronic ethanol treatment on particular opioid peptide systems in discrete regions of rat brain and pituitary.
    Seizinger BR; Bovermann K; Maysinger D; Höllt V; Herz A
    Pharmacol Biochem Behav; 1983; 18 Suppl 1():361-9. PubMed ID: 6138772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic agents differentially regulate both processing and content of alpha-N-acetylated endorphin and alpha-MSH in the ovine pituitary intermediate lobe.
    Smith AI; Wallace CA; Clarke IJ; Funder JW
    Neuroendocrinology; 1989 May; 49(5):545-50. PubMed ID: 2566941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperprolactinemia exerts a negative effect on the beta-endorphin content of the rat neurointermediate pituitary lobe.
    Lamberts SW; Uitterlinden P; Bons EG; Zuiderwijk JM; Verleun T; Oosterom R; Hackeng WH
    Endocrinology; 1984 Jun; 114(6):2349-53. PubMed ID: 6327244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin and dopamine independently regulate pituitary beta-endorphin release in vivo.
    Sapun-Malcolm D; Farah JM; Mueller GP
    Neuroendocrinology; 1986; 42(3):191-6. PubMed ID: 3005900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant dopaminergic and glucocorticoid control of pituitary proopiomelanocortin messenger ribonucleic acid and beta-endorphin levels.
    Autelitano DJ; Clements JA; Nikolaidis I; Canny BJ; Funder JW
    Endocrinology; 1987 Nov; 121(5):1689-96. PubMed ID: 2959468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-endorphin processing in pituitary and brain is sensitive to haloperidol stimulation.
    Ham J; Smyth DG
    Neuropeptides; 1985 Feb; 5(4-6):497-500. PubMed ID: 3158837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of gamma-type endorphins on alpha-MSH release in the rat.
    de Rotte AA; van Wimersma Greidanus TB; van de Buuse M; Andringa-Bakker EA; de Wied D
    Life Sci; 1985 Jul; 37(3):263-71. PubMed ID: 2409428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chronic treatment of rats with dopamine receptor drugs on the post-translational processing of Beta-endorphin in the neurointermediate lobe of the pituitary gland.
    Sweep CG; Wiegant VM
    J Neuroendocrinol; 1990 Aug; 2(4):531-7. PubMed ID: 19215385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dopaminergic drugs on hypothalamic and pituitary immunoreactive beta-endorphin concentrations in the rat.
    Locatelli V; Petraglia F; Penalva A; Panerai AE
    Life Sci; 1983 Oct; 33(17):1711-7. PubMed ID: 6314082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotransmitters and estrogen interact to affect beta-endorphin levels in castrated female rats.
    Forman LJ; Estilow S
    Peptides; 1986; 7(5):775-81. PubMed ID: 2948165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Met-enkephalin-like immunoreactivity in neurointermediate pituitary is decreased by DA receptor stimulation.
    George SR; Kertesz M
    Peptides; 1986; 7(2):277-81. PubMed ID: 3737447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.